Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML
浆细胞样树突状细胞 (pDC) 上的 CTLA-4 配体 CD86 表达可预测 CML 患者停止治疗后疾病复发的风险
期刊:Leukemia
影响因子:12.8
doi:10.1038/leu.2017.9
C Schütz, S Inselmann, S Saussele, C T Dietz, M C Mu Ller, E Eigendorff, C A Brendel, S K Metzelder, T H Bru Mmendorf, C Waller, J Dengler, M E Goebeler, R Herbst, G Freunek, S Hanzel, T Illmer, Y Wang, T Lange, F Finkernagel, R Hehlmann, M Huber, A Neubauer, A Hochhaus, J Guilhot, F Xavier Mahon, M